Inventor · disambiguated record
Edward J. Goetzl
Also filed as: GOETZL EDWARD · GOETZL EDWARD J
15 granted patents·8 pending applications·58 citations·filing 1975–2023
90Inventor score
Top patents by PatentIndex Score
23 records- 0192US9958460B2Biomarkers and diagnostic methods for Alzheimer's disease and other neurodegenerative disordersNANOSOMIX INC·Filed 2014·Granted May 1, 2018·13 cites·6 claims
- 0292US9933440B2Drug efficacy test method for dementias utilizing astrocyte-derived exosomesGOETZL EDWARD J·Filed 2017·Granted Apr 3, 2018·9 cites·5 claims
- 0389US10203342B2Biomarkers and differential diagnosis of alzheimer's disease and other neurodegenerative disordersNANOSOMIX INC·Filed 2016·Granted Feb 12, 2019·4 cites·1 claims
- 0485US9623020B2Thio compoundsUS HEALTH·Filed 2015·Granted Apr 18, 2017·5 cites·3 claims
- 0584US8927725B2Thio compoundsGREIG NIGEL H·Filed 2011·Granted Jan 6, 2015·7 cites·5 claims
- 0680US11360097B2Platelet biomarkers and diagnostic methods for vascular diseasesGOETZL EDWARD J·Filed 2016·Granted Jun 14, 2022·2 cites·7 claims
- 0768US10962555B2Purification, extraction and analyses of fetal neurally-derived exosomes in maternal blood and neonatal neurally-derived exosomes from neonatal bloodTemple University—Of the Commonwealth System of Higher Education·Filed 2017·Granted Mar 30, 2021·1 cites·5 claims
- 0863US12372538B2Exosome assay for depression and psychosis and methods and agents for treating depression, psychosis and schizophreniaGOETZL EDWARD J·Filed 2021·Granted Jul 29, 2025·0 cites·16 claims
- 0963US11619637B2Biomarkers and diagnostic methods for Alzheimer's disease and other neurodegenerative disordersNANOSOMIX INC·Filed 2018·Granted Apr 4, 2023·0 cites·2 claims
- 1061US2019137517A1Biomarkers and differential diagnosis of alzheimer's disease and other neurodegenerative disordersNANOSOMIX INC·Filed 2019·Application pending·0 cites
- 1160US9084783B2Thio compoundsUS HEALTH·Filed 2014·Granted Jul 21, 2015·0 cites·10 claims
- 1260US2023228767A1Detection of sars-cov-2 proteins and mitochondrial proteins in plasma neuron-derived extracellular vesicles and astrocyte-derived extracellular vesiclesGOETZL EDWARD J·Filed 2023·Application pending·0 cites
- 1359US4021387AEosinophilotactic tetrapeptidesHARVARD COLLEGE·Filed 1975·Granted May 3, 1977·17 cites·9 claims
- 1458US10220028B2Thio compoundsUS HEALTH·Filed 2017·Granted Mar 5, 2019·0 cites·4 claims
- 1553US2006073515A1Human polypeptide receptors for lysophospholipids and sphingolipids and nucleic acids encoding the sameGOETZL EDWARD J·Filed 2002·Application pending·0 cites
- 1652US10393760B2Specialized excitatory synaptic protein biomarkers of plasma neuronal exosomes for prediction and staging of Alzheimer's diseaseGOETZL EDWARD J·Filed 2018·Granted Aug 27, 2019·0 cites·2 claims
- 1752US2021285954A1Astrocyte-derived exosome complement protein assay for traumatic brain injury and methods and agents for treating traumatic brain injuryGOETZL EDWARD J·Filed 2021·Application pending·0 cites
- 1849US2022057501A1Endothelial Cell Derived Exosomes and Uses ThereofGOETZL EDWARD·Filed 2021·Application pending·0 cites
- 1948US2020341011A1Astrocyte exosome complement-based assay for neuroinflammation in alzheimer's disease and uses thereofGOETZL EDWARD J·Filed 2018·Application pending·0 cites
- 2042US11193943B2Endothelial cell derived exosomes and uses thereofGOETZL EDWARD·Filed 2017·Granted Dec 7, 2021·0 cites·5 claims
- 2141US2020309791A1Synaptic protein biomarkers and differential diagnosis of alzheimer's disease and other neurodegenerative disordersNANOSOMIX INC·Filed 2017·Application pending·0 cites
- 2239US2018080945A1Biomarkers and diagnostic methods for alzheimer's disease and other neurodegenerative disordersNANOSOMIX INC·Filed 2016·Application pending·0 cites
- 2333US6812335B1Human polypeptide receptors for lysophospholipids and sphingolipids and nucleic acids encoding the sameUNIV CALIFORNIA·Filed 1999·Granted Nov 2, 2004·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Edward J. Goetzl files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →